Study reveals early death predictors in COVID-19 patients with cardiac injury

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The activation of immune and thrombotic biomarkers at admission, and their ability to predict cardiac injury and mortality patterns in COVID-19, remains unclear.

Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS) – Biotech Investments

Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS) 26-Oct-2023 /

October 27, 2023

Medicare couldn’t cover Wegovy for weight loss. But now that it’s also a heart drug, the door is open

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to

March 14, 2024

Bicycle rides to $200M payday, while lung disease biotech raises $80M

Bicycle Therapeutics raised about $200 million through a public offering at $21.25 per share a few days before its new CFO is slated to step

July 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.